Patent ID: 9415032
Filing Date: 2016-08-16
CPC Classification: A61K,A61P,C07C,Y02A

Claim Text:
1. A method for treatment of a parasitic infection in a subject, comprising administering to the subject a pharmaceutical composition comprising at least one membrane activated chelator compound of formula I: or a salt, solvate, stereoisomer, or prodrug thereof, wherein R is saturated or unsaturated alkyl, cycloalkyl, arylalkyl or cycloalkyl-alkyl radical having from 1 to 28 carbon atoms which may be interrupted by any combination of 1-6 oxygen and/or nitrogen atoms, provided that no two oxygen atoms or an oxygen and a nitrogen atom are directly connected to each other; and M denotes a hydrogen or a physiologically acceptable cation, and a pharmaceutically acceptable carrier, in an amount effective to suppress or eliminate the parasite from the subject, wherein the parasitic infection is caused by infection of the subject with a protozoan organism selected from the group consisting of: